Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Off-Axis OCT Images in the PREVENT Trial: Frequency and Impact on Photoreceptor Biomarkers

Brandon J Lujan; Justin Grassmeyer; Peter Steinkamp; Clement K Chan; Maziar Lalezary; Prema Abraham; Michael J. Elman; Rahul N. Khurana; Alok S Bansal; Glenn Yiu; Yali Jia

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2760.

ARVO Annual Meeting Abstract June 2025

Choroidal Imaging Biomarkers as Predictors of Recurrent Central Serous Chorioretinopathy: A Multicenter Retrospective Study

Arman Zarnegar; Nasiq Hasan; Adarsh Gadari; Korrina Gidwani; Elizabeth J Rossin; Charles Clifton Wykoff; Samer Khateb; Rahul N. Khurana; Zachary Kroeger; Stela Vujosevic; Maurizio Battaglia Parodi; Peranut Chotcomwongse; Paisan Ruamviboonsuk; Kiran Kumar Vupparaboina; Lihteh Wu; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2765.

ARVO Annual Meeting Abstract June 2025

Demographic, clinical, and multimodal imaging characteristics in simple and complex central serous chorioretinopathy in a multicenter study: Macula Society CSCR study group

Gagan Kalra; Nasiq Hasan; Adarsh Gadari; Arman Zarnegar; Elizabeth J Rossin; Charles Clifton Wykoff; Samer Khateb; Rahul N. Khurana; Zachary Kroeger; Stela Vujosevic; Maurizio Battaglia Parodi; Peranut Chotcomwongse; Paisan Ruamviboonsuk; Carol Villafuerte-Trisolini; Glenn Yiu; Kiran Kumar Vupparaboina; Lihteh Wu; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4675.

ARVO Annual Meeting Abstract June 2025

Choroidal vascularity changes during choroidal neovascularization management in central serous chorioretinopathy

Bernard Pan; Nasiq Hasan; Adarsh Gadari; Charles Clifton Wykoff; Elizabeth J Rossin; Samer Khateb; Rahul N. Khurana; Zachary Kroeger; Glenn Yiu; Kiran Kumar Vupparaboina; Lihteh Wu; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2607.

ARVO Annual Meeting Abstract June 2023

Safety and Tolerability Study of Suprachoroidal Injection CLS-AX in Neovascular AMD Patients with Persistent Activity Following Anti-VEGF Therapy (OASIS, NCT04626128; Extension Study NCT NCT05131646)

Dennis M Marcus; Allen Hu; Mark Barakat; David M Brown; Rahul N Khurana; Joel Pearlman; Charles Clifton Wykoff; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):728.

Clinical Trials December 2021

Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I Study

PDF

Victor H. Gonzalez; Brian Berger; Roger Goldberg; Carmelina M. Gordon; Rahul N. Khurana; Raymund Angeles; Naveed Shams
TAGS: anti-vascular endothelial growth factor therapy, exudative age-related macular degeneration, persistence, phase 1 clinical trials, safety, intravitreal injections, cohort studies, endoglin, eye
Trans. Vis. Sci. Tech.. 2021; 10(14):27. https://doi.org/10.1167/tvst.10.14.27

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Checkup Mobile App to Monitor Visual Function in Diabetic Retinopathy and Age-related Macular Degeneration: The CLEAR Study

Arshad M. Khanani; Rahul N. Khurana; Lawrence J Singerman; Carol Hoang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1157.

ARVO Annual Meeting Abstract July 2018

Association Between Timing of Peak Vision Gain and Long-Term Outcomes of Ranibizumab for nAMD: A Post Hoc Analysis of HARBOR

Louis Chang; Rahul N. Khurana; Bann-mo Day; Avanti Ghanekar; Ivaylo Stoilov

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):836.

ARVO Annual Meeting Abstract July 2018

Suprachoroidal Space Alterations after Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients with Diabetic Macular Edema

Shaun Ian Retief Lampen; Rahul N. Khurana; David M Brown; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1096.

ARVO Annual Meeting Abstract June 2017

Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial

Maziar Lalezary; Steven G. Lin; Clement K Chan; Bansal S. Alok; Rahul N Khurana; Mark Wieland; Louis K Chang; James Palmer; Prema Abraham; Michael J Elman; Brandon J Lujan; Glenn Yiu

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):410.

ARVO Annual Meeting Abstract June 2017

USE OF A SMART DEVICE MOBILE APP FOR MONITORING VISUAL ACUITY AND METAMORPHOPSIA IN PATIENTS WITH DIABETIC RETINOPAHY OR AGE-RELATED MACULAR DEGENERATION

Lawrence J Singerman; Rahul N Khurana; Arshad M Khanani; Carol Hoang; Russell J. Ivanhoe; Rich G Holcomb

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3208.

ARVO Annual Meeting Abstract September 2016

Secondary ocular hypertension after dexamethasone intravitreal implant (Ozurdex) in the routine clinical practice

Kornwipa Hemarat; Jacquelyn D. Kemmer; Alexander M. Eaton; Rahul N. Khurana; Jay M Stewart

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):93.

ARVO Annual Meeting Abstract September 2016

Association between prior response to ranibizumab treatment and disease quiescence: Implications for AMD dosing

Rahul N. Khurana; Louis K Chang; Howard Shapiro; Avanti Ghanekar; Shamika Gune

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3351.

ARVO Annual Meeting Abstract April 2009

Successful Surgical Management of Fluocinolone Acetonide (Retisert) Associated Ocular Hypertension in Uveitic Patients

D. S. Grover; R. N. Khurana; M. E. Tarver Carr; J. E. Thorne

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2691.

Biochemistry and Molecular Biology August 2008

Mitochondrial Oxidative DNA Damage in Experimental Autoimmune Uveitis

PDF

Rahul N. Khurana; Jignesh G. Parikh; Sindhu Saraswathy; Guey-Shuang Wu; Narsing A. Rao
TAGS: autoimmune diseases, autoimmunity, dna damage, mitochondria, uveitis, dna, macrophages, apoptosis, retina, dna, mitochondrial
Invest. Ophthalmol. Vis. Sci.. 2008; 49(8):3299-3304. https://doi.org/10.1167/iovs.07-1607

ARVO Annual Meeting Abstract May 2008

Interleukin-8 and C-Reactive Protein Levels in Bilateral, High-Risk Non-Exudative Age-Related Macular Degeneration: The Los Angeles Latino Eye Study (LALES)

M. Javaheri; J. Chung; S. Louie; M. Torres; H. Volk; R. N. Khurana; R. Varma; the LALES Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2457.

ARVO Annual Meeting Abstract May 2008

The Incidence of Endophthalmitis Following Transconjunctival Sutureless 25-Gauge Vitrectomy Compared to 20-Gauge Vitrectomy

J. K. Chen; R. N. Khurana; Q. Nguyen; D. V. Do

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5979.

ARVO Annual Meeting Abstract May 2007

Serum Protein Profiling in Persons With Ocular Disease: The Los Angeles Latino Eye Study

J. R. Chao; R. N. Khurana; M.-Y. Lai; R. Varma; Los Angeles Latino Eye Study Group

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):330.

ARVO Annual Meeting Abstract May 2007

Pathologic Analysis of Deep Lamellar Endothelial Keratoplasty and Descemet's Stripping With Endothelial Keratoplasty Specimens

M. Javaheri; R. N. Khurana; J. G. Parikh; J. C. Song; R. E. Smith; N. A. Rao

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4709.

ARVO Annual Meeting Abstract May 2007

Photoreceptor Oxidative Damage and Apoptosis in Sympathetic Ophthalmia

J. G. Parikh; R. N. Khurana; G.-S. Wu; G. Pararajasegaram; N. A. Rao

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5136.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Off-Axis OCT Images in the PREVENT Trial: Frequency and Impact on Photoreceptor Biomarkers

Choroidal Imaging Biomarkers as Predictors of Recurrent Central Serous Chorioretinopathy: A Multicenter Retrospective Study

Demographic, clinical, and multimodal imaging characteristics in simple and complex central serous chorioretinopathy in a multicenter study: Macula Society CSCR study group

Choroidal vascularity changes during choroidal neovascularization management in central serous chorioretinopathy

Safety and Tolerability Study of Suprachoroidal Injection CLS-AX in Neovascular AMD Patients with Persistent Activity Following Anti-VEGF Therapy (OASIS, NCT04626128; Extension Study NCT NCT05131646)

Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I Study

Checkup Mobile App to Monitor Visual Function in Diabetic Retinopathy and Age-related Macular Degeneration: The CLEAR Study

Association Between Timing of Peak Vision Gain and Long-Term Outcomes of Ranibizumab for nAMD: A Post Hoc Analysis of HARBOR

Suprachoroidal Space Alterations after Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients with Diabetic Macular Edema

Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial

USE OF A SMART DEVICE MOBILE APP FOR MONITORING VISUAL ACUITY AND METAMORPHOPSIA IN PATIENTS WITH DIABETIC RETINOPAHY OR AGE-RELATED MACULAR DEGENERATION

Secondary ocular hypertension after dexamethasone intravitreal implant (Ozurdex) in the routine clinical practice

Association between prior response to ranibizumab treatment and disease quiescence: Implications for AMD dosing

Successful Surgical Management of Fluocinolone Acetonide (Retisert) Associated Ocular Hypertension in Uveitic Patients

Mitochondrial Oxidative DNA Damage in Experimental Autoimmune Uveitis

Interleukin-8 and C-Reactive Protein Levels in Bilateral, High-Risk Non-Exudative Age-Related Macular Degeneration: The Los Angeles Latino Eye Study (LALES)

The Incidence of Endophthalmitis Following Transconjunctival Sutureless 25-Gauge Vitrectomy Compared to 20-Gauge Vitrectomy

Serum Protein Profiling in Persons With Ocular Disease: The Los Angeles Latino Eye Study

Pathologic Analysis of Deep Lamellar Endothelial Keratoplasty and Descemet's Stripping With Endothelial Keratoplasty Specimens

Photoreceptor Oxidative Damage and Apoptosis in Sympathetic Ophthalmia

To View More...

You must be signed into an individual account to use this feature.